Navigation Links
GeneNews launches world's first blood test for colorectal cancer screening
Date:7/21/2008

TORONTO, July 21 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the launch of ColonSentry(TM), the world's first blood-based molecular test for colorectal cancer screening. ColonSentry(TM) is a blood test that assesses a patient's current risk of having colorectal cancer, identifying those in the asymptomatic general population with increased risk who might benefit from further more invasive diagnostic testing such as colonoscopy. This risk stratification approach allows for a more targeted application of colonoscopy which could increase the detection rate of colorectal cancer by as much as 3 fold in an asymptomatic general population. The test requires a simple blood sample. The mRNA expression of a panel of seven specific genes is measured at the molecular level by quantitative RT-PCR which results in an assessment of the patient's current risk. ColonSentry will be performed at the Company's laboratory facilities in Richmond Hill, Canada and is the first in a series of blood-based molecular tests based on the company's platform technology, the award-winning Sentinel Principle(TM).

"Each year thousands of Canadians die from colorectal cancer, the number two cause of death among all cancers in both men and women. This is a tragedy because colorectal cancer is a preventable and curable disease, but only when detected early," said Dr. Lawrence Cohen, Director of Gastroenterology at Sunnybrook Health Sciences Centre and Associate Professor of Medicine at the University of Toronto. "The launch of ColonSentry(TM) represents a leap forward in the way we currently screen for colorectal cancer. The test determines whether patients have an increased risk of having colorectal cancer. By using this risk assessment tool as the first step in a regular screening program, information obtained with ColonSentry(TM) w
'/>"/>

SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GeneNews announces management changes to support commercialization of ColonSentry(TM)
2. Genenews adds two members to its Board of Directors
3. GeneNews Announces First Quarter Results
4. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
5. GeneNews announces 2007 year end results
6. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
7. GeneNews receives ISO 13485 accreditation
8. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
9. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
10. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
11. Norgen Biotek Corp. Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...RNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE ...osenthal, Professor of Immunology and Microbiology...cine and Pharmacy, reported on work conducted in c...ic and CEL-SCI on CEL-SCI,s LEAPS vaccine technolo...ine: "All Things Considered" Conference in Crystal...
(Date:11/9/2009)...oduct release is a research industry first, allowi...es and research safety study data to be managed in... Cedar Knolls, NJ (PRWEB) November 9, 2009 -- X...unveiled Pristima™ VM, an integrated enterpr... track the use and care of veterinary research sub...
(Date:11/8/2009)...l temperatures and energy costs continue to soar, ...inable future. An attractive replacement for gas...ine in Genome Research ( www.genome.org ), scien...hanol-producing microorganisms, uncovering genetic...hnologies needed to implement production on a glob...
(Date:11/7/2009)... 7, Research projects in the areas...this evening, as Tim Kunisky of Livingston, NJ and... Audubon, PA received the highest honors at the Re...n Math, Science & Technology, the nation,s pre...p://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSL...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6
...Corporation,s (CellCyte) (OTC Bulletin Board: CCYG... the 2008 San Francisco RedChip Small-Cap Investor...ic Daylight Time at the,Palace Hotel in San Franci...e conference at which they will have a prototype d...actor., The presentation will be Web cast live wi...
...to develop,educational opportunities for students ...oods Learning Center (TWLC) are collaborating to p...cent report by the National,Research Council studi...at,students are more likely to have increased scie...n hands-on experiences," says Jeff Harford, LI-COR...
...us,shareholder questions, CEL-SCI CORPORATION (Ame...on of its manufacturing facility near Baltimore,Ma...omprise 73,000 square,feet and will be used to man...roduct. This dedicated facility will produce the M...hase III clinical trial for first-line,therapy of ...
Other Biology Technology:LI-COR(R) Biosciences and Tiger Woods Learning Center Collaborate to Develop High School Curriculum in Genetics 2CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter 2CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter 3
(Date:11/9/2009)...2009 / b3c newswire / - Today, TNO, a Dutch con...American organization for contract research and co... a letter of intent with regard to TNOs dynamic i...f intent proposes a collaboration in which Seventh...ation in North America. The TIM systems will be us...
(Date:11/9/2009)...utritionist whose research was instrumental in add...fants and Children (WIC) food subsidy will receive...nding achievement in the field of maternal-fetal n...fessor in the Department of Community Health Scien...chool of Public Health, will receive the award to...
(Date:11/8/2009)...ULTS WITH INTELLECTUAL DISABILITIES: AN OPPORTUNIT...tudy involving adults with intellectual disabiliti...health knowledge after taking a semi-weekly class ...nally accepted term for mental retardation, have s...ty and preventable chronic diseases compared to th...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Shoulder Surgery Doesn 26apos 3Bt Prevent Return to Sports According to New Study presented at AOSSM Annual Meeting 51295 1Shoulder Surgery Doesn 26apos 3Bt Prevent Return to Sports According to New Study presented at AOSSM Annual Meeting 51295 2Shoulder Surgery Doesn 26apos 3Bt Prevent Return to Sports According to New Study presented at AOSSM Annual Meeting 51295 3Shoulder Surgery Doesn 26apos 3Bt Prevent Return to Sports According to New Study presented at AOSSM Annual Meeting 51295 4Shoulder Surgery Doesnt Prevent Return to Sports 4709 1Shoulder Surgery Doesnt Prevent Return to Sports 4709 2Seals quickly respond to gain and loss of habitat under climate change 9199 1Seals quickly respond to gain and loss of habitat under climate change 9199 2Seals quickly respond to gain and loss of habitat under climate change 9199 3
...S SERVICE, Weekly Press Package, November 14, 2007... (ACS) News Service Weekly press package (PressPac...d journals and Chemical & Engineering News. With m...largest scientific society. Please cite the indivi... the source of this information. , , , ARTICLE ...
...GE, Mass.--MIT researchers have devised a novel wa...lls that model the full-sized organ. The work coul...entially harmful to the liver and reduce the costs...ity is one of the main reasons pharmaceutical comp...rugs slip through approval processes due in part t...
...GE, MA--MIT scientists have devised remotely contr...tromagnetic field, release drugs to attack tumors....sue of Advanced Materials, could lead to the impro... In earlier work the team, led by Sangeeta Bhatia,...-MIT Division of Health Sciences & Technology (HST...
Other Biology News:American Chemical Society's Weekly PressPac -- Nov. 14, 2007 2American Chemical Society's Weekly PressPac -- Nov. 14, 2007 3American Chemical Society's Weekly PressPac -- Nov. 14, 2007 4American Chemical Society's Weekly PressPac -- Nov. 14, 2007 5American Chemical Society's Weekly PressPac -- Nov. 14, 2007 6American Chemical Society's Weekly PressPac -- Nov. 14, 2007 7American Chemical Society's Weekly PressPac -- Nov. 14, 2007 8American Chemical Society's Weekly PressPac -- Nov. 14, 2007 9American Chemical Society's Weekly PressPac -- Nov. 14, 2007 10MIT: 'Micro' livers could aid drug screening 2MIT: 'Micro' livers could aid drug screening 3MIT: Remote-control nanoparticles deliver drugs directly into tumors 2
ALDEFLUOR, Stem Cell Identification, Kit from StemCell Technologies, Inc.
Freund's Incomplete Adjuvant, Modified from Calbiochem
Imject Freund's Incomplete Adjuvant (FIA) from Pierce Biotechnology, Inc.
Freund's Complete Adjuvant, Modified, Mycobacterium butyricum from Calbiochem
Biology Products: